A
A. Pieter Kappetein
Researcher at Erasmus University Medical Center
Publications - 116
Citations - 18447
A. Pieter Kappetein is an academic researcher from Erasmus University Medical Center. The author has contributed to research in topics: Percutaneous coronary intervention & Conventional PCI. The author has an hindex of 40, co-authored 101 publications receiving 16715 citations. Previous affiliations of A. Pieter Kappetein include Leiden University Medical Center.
Papers
More filters
Journal ArticleDOI
A meta-analysis on clinical outcomes after transaortic transcatheter aortic valve implantation by the Heart Team.
TL;DR: In this meta-analysis of observational studies, transaortic TAVI appears to be a safe procedure with low complication rates.
Journal ArticleDOI
Subgroup analyses in trial reports comparing percutaneous coronary intervention with coronary artery bypass surgery
TL;DR: The authors evaluated subgroup analyses in reports from RCTs comparing percutaneous coronary intervention (PCI) with coronary artery bypass grafting (CABG) and found low credibility due to methodological or reporting issues.
Journal ArticleDOI
Influence of final kissing balloon inflation on long-term outcomes after PCI of distal left main bifurcation lesions in the EXCEL trial
Annapoorna Kini,George Dangas,Usman Baber,Yuliya Vengrenyuk,David E. Kandzari,Martin B. Leon,Marie-Claude Morice,Patrick W. Serruys,A. Pieter Kappetein,Joseph F. Sabik,Ovidiu Dressler,Roxana Mehran,Samin K. Sharma,Gregg W. Stone +13 more
TL;DR: In the EXCEL trial, the performance of FKBI after PCI of distal LM bifurcation lesions was not associated with improved 4-year clinical outcomes regardless of whether 1 stent or ≥2 stents were implanted.
Journal ArticleDOI
Comparison of Outcomes After Transcatheter vs Surgical Aortic Valve Replacement Among Patients at Intermediate Operative Risk With a History of Coronary Artery Bypass Graft Surgery: A Post Hoc Analysis of the SURTAVI Randomized Clinical Trial.
Michael J. Reardon,Robin H. Heijmen,Nicolas M. Van Mieghem,Mathew R. Williams,Steven J. Yakubov,Daniel R. Watson,Neal S. Kleiman,John V. Conte,Atul Chawla,David Hockmuth,George Petrossian,Newell Robinson,A. Pieter Kappetein,Shuzhen Li,Jeffrey J. Popma +14 more
TL;DR: Both TAVR and SAVR were safe for intermediate-risk patients with aortic stenosis and prior CABG surgery and the transcatheter approach facilitated faster improvement in quality of life and better exercise capacity at 1-year follow-up.
Journal ArticleDOI
Radial versus femoral artery access in patients undergoing PCI for left main coronary artery disease: analysis from the EXCEL trial.
Shmuel Chen,Björn Redfors,Yangbo Liu,Ori Ben-Yehuda,Marie-Claude Morice,Martin B. Leon,David E. Kandzari,Roxana Mehran,Nicholas Lembo,Adrian P. Banning,Béla Merkely,A. Pieter Kappetein,Joseph F. Sabik,Patrick W. Serruys,Gregg W. Stone +14 more
TL;DR: In the EXCEL trial, PCI of LM disease with TRA was associated with comparable early and late clinical outcomes to TFA, and the mean number of vessels and lesions treated was higher in TFA patients, although the SYNTAX score was similar in both groups.